Qinecsa
Qinecsa is a pharmacovigilance and drug safety services provider that supports pharmaceutical and biotech companies with end‑to‑end safety operations, including case processing, signal management, medical review, and regulatory reporting. It combines specialized safety operations teams with proprietary technology platforms to help clients manage global safety data and comply with regulatory requirements across the product lifecycle. The company generates revenue through outsourced safety services and technology-enabled safety solutions delivered on a contract basis.
- Revenue
- $50M - $250M
- Employees
- 201 - 1,000
- Founded
- 2021
- Headquarters
- Londonderry County Borough, United Kingdom
Qinecsa customers on Arbolus
Customers who reviewed Qinecsa
Seniority of Qinecsa customers
Most people who reviewed Qinecsa hold Director roles (80%), followed by C-Suite (10%) and Manager (10%).
- Director 80%
- C-Suite 10%
- Manager 10%
Customers sample
Employer names and spend open in the full report, along with the other 7 customers.
What 10 Arbolus experts think of Qinecsa
Overall sentiment: Positive
NPS scores for Qinecsa are weighted toward promoters, with over 70% sharing scores of 8 or above; a minority are neutral or unsure. 60% of experts express explicit renewal intent while others remain open or cautious, especially those piloting the platform. Stickiness is highest among mid- to large-sized enterprises and organizations with expansive compliance needs. Key positive themes are regulatory expertise, reliability, and operational efficiency, while caution centers on advanced AI features and global scalability.
Everything 10 customers told us about Qinecsa.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
20 Net Promoter Score, from 10 scored reviews- Promoters 4
- Passives 4
- Detractors 2
Praised
- Modernized User Experience
- AI Automation for End-to-End Workflows
- Growth in Compliance-Focused Segments
- Specialized Regulatory and PV Expertise
Criticised
- UI and Customization Gaps
- Limited Advanced AI Integration
- Scalability for Large Pharma
- Compliance or Quality Failures
What Qinecsa customers say
Specialized Regulatory and PV Expertise
“I have confidence in Qinecsa’s regulatory and pharmacovigilance expertise, which supports our global compliance and ensures consistent audit readiness.”
Operational Flexibility and Fast Onboarding
“I value the agility and flexibility of this vendor, as their implementation process is much faster and more responsive than larger, traditional providers.”
Comprehensive Suite Covering All Safety Needs
“I rely on Qinecsa’s broad platform that streamlines everything from case management to regulatory compliance while supporting scalability for growth.”
Renewal intent
Plan to renew 56%Plan to renew, by seniority
- 0% 1 answer
- 71% 7 answers
- 0% 1 answer
- 8.8/10 Average score from customers who will renew
- 6.3/10 Average score from undecided customers
- 0/10 Average score from customers not renewing
Top alternatives
Most weighed by Qinecsa customersReport
For people who use Qinecsa
Do you use Qinecsa at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 10 customers of Qinecsa have already contributed
Takes a few minutes. Your identity stays anonymous.